Specsavers

One-third of Ontarians Haven’t Had an Eye Exam in Over Three Years

One-third of Ontarians haven’t had an eye exam in over three years, and 55% feel as though eyewear is currently not affordable for Canadians, a recent poll found. That’s why Specsavers is announcing an investment of $50 million into Ontario to enhance eye health outcomes, reduce preventable blindness and redefine accessible eye care.

“Our Government is pleased to welcome Specsavers to Ontario,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “This $50 million investment will create 1500 jobs for the people of Ontario and is further proof that by lowering the cost of doing business by $7 billion each and every year, we have made our province a more attractive place to invest.”

This investment is aimed at creating business ownership opportunities for opticians and independent optometrists, helping them to achieve success while remaining autonomous and patientcare focused.

“Specsavers’ investment into Ontario aligns with our purpose of changing lives through better sight,” said Bill Moir, General Manager, Specsavers Canada. “Seventy-five per cent of vision loss and blindness is preventable or treatable with early intervention. With Specsavers’ global scale, we are able to lower the cost of eyewear for Ontarians, which helps remove a significant barrier to getting regular eye exams, especially at a time when Ontarians are being more careful with their money due to rising costs.”

Specsavers Canada is focused on following the clinical evidence from Specsavers in Australia, where consistent use of OCT as part of standard care has enabled a significant increase in early detection and management of conditions like glaucoma. This ensures patients are made aware of any risks they have so their condition can be managed preventatively before vision is lost.

Specsavers’ investment into Ontario is part of a $100 million investment plan for Canada, which was announced earlier this year to open 200 locations across the country. This multi-million-dollar investment will cover 100% of location start-up costs for optometrists and opticians who become Specsavers business owners. All optometry clinics and optical stores will be locally owned, creating new jobs and allowing owners to focus on the specific needs of their community.

Source : Specsavers

Featured Posts

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read More

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read More

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read More

Winners of the 30th SILMO d’Or

And here are the winners!

Read More

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more

Transitions and the OAC Now Accepting Applications for the 2023 Students of Vision Scholarship Program

This year students will be asked to discuss the importance on diversity and multicultural efforts in eyecare.

Learn More

Karen Walsh Appointed to Lead CooperVision Global Professional Affairs

Full Scope Approach Reflects Global Growth and ECP-Centric Focus

Read more

Lightec, Where the Lightness is Paramount

While the comfort and the lightness are at the heart of Lightec's philosophy, the design is never compromised.

Read more

Using Gene Therapy to Treat Genetic Eye Disease Aniridia

In 2020, Fighting Blindness Canada awarded Dr. Elizabeth Simpson at the University of British Columbia a research grant of $297,000 to support the development of a potential gene therapy for the inherited eye disease, aniridia.

Read more

Winners of the 30th SILMO d’Or

And here are the winners!

Read more